Russell Investments Group, Ltd.

Position in CABA — Cabaletta Bio, Inc.

CIK 1692234 Seattle, WA

Position in CABA

as of Jun 30, 2026 · filed Aug 6, 2026 Compact

Position Value

$30,916

+$28,391 QoQ

Shares Held

9,941

+958.7% QoQ

Ownership

0.006%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#117

of 139 holders

Holding Since

Jun 2020

13 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Russell Investments Group, Ltd. holds $1,494,413,888 across 308 Biotechnology names. CABA ranks #249 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	336,990	$167,393,033
2	REGN	Regeneron Pharmaceuticals, Inc.	230,151	$143,508,345
3	RPRX	Royalty Pharma plc	1,694,250	$94,996,587
4	INCY	Incyte Corp	425,616	$48,247,822
5	ALNY	Alnylam Pharmaceuticals, Inc.	158,228	$47,631,369
6	BMRN	Biomarin Pharmaceutical Inc	783,148	$44,811,725
7	LGND	Ligand Pharmaceuticals Inc	120,304	$38,026,888
8	PTCT	Ptc Therapeutics, Inc.	418,025	$34,098,295

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$30,916	9,941	+958.7%	Shares	Defined	2026-08-06
2026-03-31	$2,525	939	0.0%	Shares	Defined	2026-05-08
2025-12-31	$2,056	939	0.0%	Shares	Defined	2026-02-17
2025-09-30	$2,197	939	0.0%	Shares	Defined	2025-11-13
2025-06-30	$1,427	939	-40.3%	Shares	Defined	2025-08-13
2024-12-31	$3,572	1,574	+602.7%	Shares	Defined	2025-02-13
2024-06-30	$1,675	224	+622.6%	Shares	Defined	2024-08-08
2024-03-31	$528	31	+121.4%	Shares	Defined	2024-05-08
2023-09-30	$213	14	-100.0%	Shares	Defined	2023-11-13
2021-03-31	$378,054	34,059	0.0%	Shares	Sole	2021-05-10
2020-12-31	$425,055	34,059	-57.5%	Shares	Defined	2021-02-08
2020-09-30	$869,411	80,204	-20.7%	Shares	Sole	2020-11-09
2020-06-30	$1,126,978	101,165	—	Shares	Sole	2020-08-05
No filing history on record for this holder in this stock.